KISS circulators
The KISS circulators are ideally suited for routine laboratory applications such as sample temperature control, analyses and material testing as well as the external temperature control of measuring devices and test setups.
KISS® Cooling and heating circulators for laboratory applications from -30 to +200 °C
The new KISS circulators are ideally suited for routine laboratory applications. Customers can choose from over 50 models for heating and cooling. Apart from an RS232 interface, it now also has a USB interface as standard. Another new addition is a modern OLED display with intuitive menu navigation. The new white display can be read well at all times, even in brighter environments. Another advantage is the simultaneous display of actual temperature and set point value, as well as high/low temperature limit values. As a factory fitted option, a connection socket for a Pt100 sensor can be fitted.
All models are equipped with an over temperature and low level protection according to Safety class III/FL (DIN 12876) and are thus also suited for flammable liquids. The circulation pump generates a capacity of 14 l/min; 0.25 bar on the pressure side and 10.5 l/min; 0.17 bar on the suction side and thus ensures optimal mixing and homogeneous temperatures. The KISS range includes baths made of transparent polycarbonate (up to +100°C) or high-grade stainless steel (up to +200°C) as well as refrigeration circulators for working temperatures down to -30°C.
Contact details:
Company name: Peter Huber Kältemaschinenbau AG
Website: www.huber-online.com
E-mail: info@huber-online.com
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
